| LDR | | 00000nmm u2200205 4500 |
| 001 | | 000000329904 |
| 005 | | 20241016161544 |
| 008 | | 181129s2018 ||| | | | eng d |
| 020 | |
▼a 9780438033535 |
| 035 | |
▼a (MiAaPQ)AAI10747223 |
| 035 | |
▼a (MiAaPQ)unc:17519 |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 049 | 1 |
▼f DP |
| 082 | 0 |
▼a 362 |
| 100 | 1 |
▼a Dragomani, Rebecca. |
| 245 | 10 |
▼a No Child Left Behind: A Quality Improvement Clinical Implementation to Improve the Treatment Outcomes, Quality of Care, and Quality of Life for School-Aged Children with Attention-Deficit/Hyperactivity Disorder at a Rural Primary Care Practice. |
| 260 | |
▼a [S.l.] :
▼b The University of North Carolina at Chapel Hill.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 91 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-10(E), Section: B. |
| 500 | |
▼a Adviser: Victoria Soltis-Jarret. |
| 502 | 1 |
▼a Thesis (D.N.P.)--The University of North Carolina at Chapel Hill, 2018. |
| 520 | |
▼a Background and Rationale: Children with attention deficit hyperactivity disorder (ADHD) consistently report lower quality of life than their neurotypical peers and are at substantially increased risk for development of a comorbid psychiatric dis |
| 520 | |
▼a Problem: Genetic differences contribute to the wide variability of response to ADHD medications but are not considered in treatment decisions. Quality of life, which correlates with the development of psychiatric comorbidities, is rarely assesse |
| 520 | |
▼a Purpose: The project aimed to improve the quality of care, treatment outcomes, and quality of life for school-aged children with ADHD at a primary care practice by implementing a comprehensive bundle of practice changes that individualize treatm |
| 520 | |
▼a Methodology: The impact of routine pharmacogenomic testing on the incidence of ADHD medication side effects and change in behavioral symptoms was evaluated using retrospective chart review data. A convenience sample of 52 charts included 26 char |
| 520 | |
▼a Results: All QI initiatives were fully adopted. Pharmacogenomic testing was associated with fewer moderate and severe ADHD medication side effects (PGT 1.1 vs. No PGT 2.4) and greater differences in behavioral symptom scores (PGT -32 vs. NPGT -1 |
| 520 | |
▼a Conclusion: The results support the continued use of pharmacogenomic testing prior to prescribing medication to children for ADHD, use of standardized assessments of response, and quality-of-life assessments to identify children at higher risk f |
| 590 | |
▼a School code: 0153. |
| 650 | 4 |
▼a Mental health. |
| 650 | 4 |
▼a Nursing. |
| 690 | |
▼a 0347 |
| 690 | |
▼a 0569 |
| 710 | 20 |
▼a The University of North Carolina at Chapel Hill.
▼b Nursing. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-10B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0153 |
| 791 | |
▼a D.N.P. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996922
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자
▼b 관리자 |